Myeloma bone disease: A constant problem in the changing landscape of myeloma management.
This publication reviews advances in the management of myeloma bone disease, a significant cause of morbidity despite im...
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP.
- Post category:Hematologic Cancers
- Reading time:1 min read
This international registry-based study by the EBMT evaluated conditioning regimens in children under 2 years undergoing...
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.
- Post category:Hematologic Cancers
- Reading time:1 min read
This study evaluated the prognostic impact of myelodysplasia-related (MR) gene mutations in 4,978 intensively treated ac...
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.
- Post category:Hematologic Cancers
- Reading time:1 min read
This real-world study from the Center for International Blood and Marrow Transplant Research evaluated tisagenlecleucel,...
Racial disparities in clonal hematopoiesis and their impact on hematologic malignancies.
- Post category:Hematologic Cancers
- Reading time:1 min read
This study analyzed clonal hematopoiesis of indeterminate potential (CHIP) and its progression to hematologic malignanci...
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.
- Post category:Hematologic Cancers
- Reading time:1 min read
This multicenter real-world study evaluated belumosudil (BEL), a selective ROCK2 inhibitor, in 46 heavily pretreated pat...